Latest Macular degeneration Stories
Novel Therapies Demonstrating Evidence of Superior Head-to-Head Efficacy Will Expand the Role of Adjunct Therapy, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
CMS decision will provide patients access to VisionCare's AMD telescope in surgical facilities where 80% of ophthalmic surgeries are conducted SARATOGA, Calif., Nov.
On Saturday, November 15, 2014 the South Florida community will have the opportunity to walk at Hugh Taylor Birch State Park in Fort Lauderdale, in support of finding a cure for blinding retinal
Desire for Greater Efficacy and Improved Convenience Drive Perceived Value of Emerging Therapies for Wet Form of the Disease, According to Findings from Decision Resources Group BURLINGTON,
Implanted Lens System is a Novel Solution for Dry AMD Symptoms CHICAGO, October 21, 2014 /PRNewswire/ -- London Eye Hospital Pharma, a London based medical device
Ophthotech/Novartis's Fovista Will Exceed $500 Million in 2023 Sales as a Treatment for the Wet Form of the Disease, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
TARRYTOWN, N.Y., Oct. 17, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Licensing Agreement Signed For Canadian Market Expected Revenue In Excess Of $30MM USD (PRWEB) October 16, 2014 The Eye Machine, LLC today announced
- AIMing to establish a new treatment for ophthalmologic diseases - TOKYO, Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma Inc.
MOUNTAIN VIEW, Calif., Oct.
- The word or words serving to define another word or expression, as in a dictionary entry.